Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/ATH stock hub

ASX/ATH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/ATHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
119.6M
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/ATH
In the news

Latest news · ASX/ATH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 20.4P75 41.2
Trailing P/En/a
P25 14.2P50 19.2P75 35.1
ROE-47
P25 -118.7P50 -49.4P75 -1.2
ROIC-35.3
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/ATH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
174
Groups with data
11
Currency
AUD
Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Australia
Country code
AU
Employees
9
Employees Change
-1%
Employees Change Percent
-10
Enterprise value
AUD 70.5M
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Biotechnology
Isin
AU0000043945
Last refreshed
2026-05-10
Market cap
AUD 119.6M
Price
AUD 0.01
Price currency
AUD
Rev Per Employee
737,380.11x
Sector
Healthcare
Sic
2836
Symbol
asx/ATH

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-12.2%
EV Earnings
-4.83x
EV/Sales
10.63x
P/B ratio
2.2x
P/S ratio
18.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-264.66%
EBITDA Margin
-264.46%
Gross margin
97.55%
Gross Profit
AUD 6.5M
Gross Profit Growth
21.88%
Gross Profit Growth Q
75.36%
Gross Profit Growth3 Y
19.38%
Gross Profit Growth5 Y
12.26%
Net Income
AUD -14.6M
Net Income Growth Years
1%
Pretax Margin
-217.9%
Profit Margin
-219.85%
Profit Per Employee
AUD -1.6M
ROA
-32.54
Roa5y
-35.37
ROCE
-32.33
ROE
-47.02
Roe5y
-63.09
ROIC
-35.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

13
MetricValue
Cagr10y
-17.58%
Cagr15y
-17.85%
Cagr1y
22.24%
Cagr20y
-13.71%
Cagr3y
16.26%
Cagr5y
-17.63%
EPS Growth Quarters
6
EPS Growth Years
2
Revenue Growth
78.18x
Revenue Growth Q
74.57x
Revenue Growth Years
2x
Revenue Growth3 Y
18.19x
Revenue Growth5 Y
11.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
AUD 0.2
Assets
AUD 56.9M
Cash
AUD 49.2M
Current Assets
AUD 56.8M
Current Liabilities
AUD 2.6M
Debt
AUD 98,449
Debt Equity
AUD 0
Equity
AUD 54.3M
Liabilities
AUD 2.7M
Long Term Assets
AUD 95,882
Long Term Liabilities
AUD 65,461
Net Cash
AUD 49.1M
Net Cash By Market Cap
AUD 41.05
Net Cash Growth
1,008.22%
Net Debt Equity
AUD -0.9
Tangible Book Value
AUD 54.3M
Tangible Book Value Per Share
AUD 0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
21.98
Net Working Capital
AUD 5.1M
Quick ratio
21.68
Working Capital
AUD 54.2M
Working Capital Turnover
AUD 0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-74.72%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-85.53%
1Y total return
22.22%
200-day SMA
0.01
3Y total return
57.14%
50-day SMA
0.01
50-day SMA vs 200-day SMA
50under200
5Y total return
-62.07%
All Time High
2.5
All Time High Change
-99.56%
All Time High Date
2002-03-12
All Time Low
0
All Time Low Change
450%
All Time Low Date
2024-08-07
ATR
0
Ch YTD
37.5
High
0.01
High52
0.02
High52 Date
2025-07-28
High52ch
-35.29%
Low
0.01
Low52
0.01
Low52 Date
2026-03-30
Low52ch
57.14%
Ma50ch
25%
Price vs 200-day SMA
11.11%
RSI
59.91
RSI Monthly
54.36
RSI Weekly
57.94
Sharpe ratio
0.78x
Sortino ratio
1.41
Total Return
-74.72%
Tr YTD
37.5
Tr15y
-94.76%
Tr1m
37.5%
Tr1w
4.76%
Tr3m
22.22%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
AUD -17.6M
Operating margin
-264.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
8,311,780,939%
Net Borrowing
-125,095
Shares Insiders
4.73%
Shares Institutions
34.59%
Shares Out
10,875,416,329
Shares Qo Q
36.08%
Shares Yo Y
74.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

50
MetricValue
Average Volume
6,000,023.75x
Bv Per Share
0
Ch10y
-85.53
Ch15y
-94.76
Ch1m
37.5
Ch1w
4.76
Ch1y
22.22
Ch20y
-94.76
Ch3m
22.22
Ch3y
57.14
Ch5y
-62.07
Ch6m
22.22
Change
10%
Change From Open
10
Close
0.01
Days Gap
0
Depreciation Amortization
13,570
Dollar Volume
14,776.7
Earnings Date
2026-05-11
EBIT
AUD -17.6M
EBITDA
AUD -17.6M
EPS
AUD -0
F Score
3
Financing CF
58,572,454
Fiscal Year End
June
Founded
1,997
Income Tax
AUD 129,622
Is Primary Listing
1
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Ma150
0.01
Ma150ch
22.22%
Ma20
0.01
Ma20ch
11.11%
Net CF
44,663,988
Next Earnings Date
2026-05-11
Open
0.01
Position In Range
100
Ppne
95,882
Price Date
2026-05-08
Ptbv Ratio
2.2
Relative Volume
0.22x
Revenue
6,636,421x
SBC By Revenue
36.17x
Share Based Comp
2,400,367
Tax By Revenue
1.95x
Tr20y
-94.76%
Tr6m
22.22%
Volume
1,343,332
Z Score
15.68
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ASX/ATH pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/ATH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+22.2%
S&P 500 1Y: n/a
3Y total return
+57.1%
S&P 500 3Y: n/a
5Y total return
-62.1%
S&P 500 5Y: n/a
10Y total return
-85.5%
S&P 500 10Y: n/a
Ownership

Who owns ASX/ATH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+34.6%
Share of float held by funds and institutions
Insider ownership
+4.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+74.7%
Negative means the company is buying back shares.
Technical

ASX/ATH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.9
Neutral momentum band
Price vs 200-day MA
+11.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.78
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/ATH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/ATH stock rating?

asx/ATH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/ATH analysis?

The full report lives at /stocks/asx/ATH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/ATH?

The latest report frames asx/ATH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/ATH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.